Impact of a Real-time Mentoring Tool on Antibiotic Prescription (medAL-mentor)

Sponsor
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05901155
Collaborator
Swiss Tropical & Public Health Institute (Other), Ifakara Health Institute (Other), Mbeya Medical Research Centre-National Institute for Medical Research (Other)
12,800
40
2
3.8
320
83.2

Study Details

Study Description

Brief Summary

The goal of this ancillary study, part of the DYNAMIC project, is to reduce antibiotic prescription and improve the quality of care for children in primary care in Tanzania using a near real-time mentoring tool (called medAL-mentor), based on a monitoring and benchmarking dashboard and feedback by the monitoring team. The main question to be answered is: Can real-time mentoring, based on clinical decision support algorithm data, improve healthcare workers' compliance with guidelines - and therefore quality of care for paediatric outpatients? Health providers in participating health facilities will receive either the medAL-mentor tool and feedback from the monitoring team (intervention group), or standard mentoring (control group), so that the impact on antibiotic prescription and other quality of care indicators can be compared between the two arms.

Condition or Disease Intervention/Treatment Phase
  • Device: MedAL-mentor
N/A

Detailed Description

ePOCT+ is a paediatric digital clinical decision support algorithm for health workers in primary care facilities in Tanzania. The objective is to improve the integrated management of acutely ill children aged 1 day to 14 years and reduce inappropriate antibiotic prescriptions.

Preliminary findings from the first phase of the DYNAMIC project, an open-label cluster randomized controlled study performed in 40 health facilities, showed a reduction in antibiotic prescription by health providers from about 70% in the control arm to 23% in health facilities using ePOCT+, with similar clinical outcomes in children at day 7. Nevertheless, uptake of ePOCT+ and antibiotic prescription in the intervention arm were very heterogeneous across health facilities.

Benchmarking in healthcare is defined as "a process of comparative evaluation and identification of the underlying causes leading to high levels of performance". The findings and experiences of different institutions are shared, and elements of best practices are adopted to improve performance. Benchmarking has been promoted for years by infectious diseases societies as a component of hospital antimicrobial stewardship programs, to reduce antibiotic prescription. Benchmarking has also been shown to be an effective incentive to improve the quality of care in various settings, including primary care practice. Unfortunately, published initiatives have largely come from high-income countries.

In the context of the DYNAMIC project, we developed a near real-time mentoring tool, medAL-mentor, based on a monitoring and benchmarking dashboard using data collected through ePOCT+. The tool provides direct feedback to health workers on their performance, based on several clinical indicators (including antibiotic prescription), in comparison with data from other health facilities. The monitoring team will target calls and monitoring visits to health facilities based on these indicators and use the dashboard to facilitate discussions with healthcare workers.

This ancillary study, MedAL-mentor, aims to assess whether this real-time mentoring tool based on data generated by a clinical decision support algorithm, as well as feedback from the mentoring team, improves healthcare workers' compliance with guidelines - and therefore the quality of care for sick children at primary care level.

More specifically, the study objectives are :
Primary objective :

To determine whether the provision of medAL-mentor, a digital mentoring tool, decreases antibiotic prescription by primary care clinicians using a clinical decision support algorithm (ePOCT+) for the management of sick children

Secondary objectives are :
  1. To assess the impact of medAL-mentor on clinicians' uptake of ePOCT+

  2. To assess the impact of medal-mentor on clinicians in terms of :

  3. Performance of key measurements and assessment of signs by clinicians

  4. Compliance with the recommendations related to point-of-care tests (for malaria and haemoglobin)

This open-label, parallel cluster randomized controlled study is embedded in the second phase of the DYNAMIC project in Tanzania. The intervention consists of providing direct access to medAL-mentor to the healthcare workers. The mentoring team will target calls and monitoring visits to health facilities based on medAL-mentor indicators and use the dashboard to facilitate discussions with healthcare workers during the monitoring visits. Since the intervention takes place at the healthcare worker level and their practices are influenced by the context of the health facility they are working in, randomization at the health facility level rather than at the health worker level was chosen.

40 health facilities using ePOCT+ for the first time during the second phase of the DYNAMIC project will be randomly selected and assigned to two groups (randomization 1:1, intervention: control). Health workers in health facilities randomized to the intervention group will receive feedback on their performance through direct access to medAL-mentor and regular mobile messages, as well as targeted phone calls and visits by the monitoring team based on the medAL-mentor dashboard. Health facilities from the control group will receive standard monitoring (regular messages to check for any issues and regular site visits), without access to medAL-mentor (neither for the health workers nor for the monitoring team).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
12800 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The study involves two arms: intervention and control. Health facilities will serve as clusters, with half of the facilities (20) receiving the intervention and the other half serving as controls (20). Health facilities will be randomized to their respective study arm. A parallel design (all health facilities start at the same time) will be used.The study involves two arms: intervention and control. Health facilities will serve as clusters, with half of the facilities (20) receiving the intervention and the other half serving as controls (20). Health facilities will be randomized to their respective study arm. A parallel design (all health facilities start at the same time) will be used.
Masking:
None (Open Label)
Masking Description:
Masking is not possible.
Primary Purpose:
Diagnostic
Official Title:
Impact of medAL-mentor, a Real-time Mentoring and Benchmarking Tool, on Antibiotic Prescription Among Children in Primary Health Care Facilities in Tanzania
Anticipated Study Start Date :
Jun 5, 2023
Anticipated Primary Completion Date :
Sep 30, 2023
Anticipated Study Completion Date :
Sep 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: MedAL-mentor

In health facilities allocated to the medAL-mentor arm, the intervention will consist in : Providing tablets with ePOCT+ and initial training for use by healthcare workers Access to medAL-mentor for healthcare workers and the monitoring team Regular (at least every 2 weeks) supportive messages sent by the monitoring team to healthcare workers providing feedback from medAL-mentor Targeted phone calls and health facilities visits by the monitoring team based on medAL-mentor review Monitoring will be performed by the study team.

Device: MedAL-mentor
MedAL-mentor is a near real-time monitoring and benchmarking dashboard based on data collected through ePOCT+, providing direct feedback on several clinical indicators (antibiotic prescription, performance of key measurements, signs, and diagnostic tests).

No Intervention: Routine mentoring

In health facilities allocated to the control arm, tablets with ePOCT+ will also be provided to healthcare workers with initial training, but subsequent mentoring will be conducted routinely: No access to medAL-mentor for healthcare workers or the monitoring team At least one message sent by the monitoring team to healthcare workers every two weeks, to inquire about any issues and trigger a site visit if needed At least one visit from the monitoring team in each health facility every two months Monitoring will be performed by the study team.

Outcome Measures

Primary Outcome Measures

  1. Percentage of children prescribed an antibiotic in the intervention group (medAL-mentor) as compared to the control group (routine mentoring) [Day 0 (by the end of the consultation)]

    Number of children for whom at least one systemic (oral or parenteral) antibiotic has been prescribed during consultation, over all eligible children, as reported by the healthcare workers in a routine registry

Secondary Outcome Measures

  1. Percentage of consultations with eligible children performed using ePOCT+ [Day 0 (by the end of the consultation)]

    Number of consultations completed with ePOCT+, over all consultations with eligible children as reported in a routine registry

  2. Percentage of children in whom key signs have been checked by healthcare workers [Day 0 (by the end of the consultation)]

    Number of children in whom key signs (temperature, weight, mid-upper arm circumference (MUAC), respiratory rate) have been checked by healthcare workers, over the total number of children for whom this was recommended, as reported by healthcare workers in ePOCT+

  3. Percentage of children for whom appropriate diagnostic tests have been performed by healthcare workers [Day 0 (by the end of the consultation)]

    Number of children for whom diagnostic tests (haemoglobin and malaria tests) have been performed by healthcare workers, over the total number of children for whom diagnostic tests were recommended, as reported by healthcare workers in ePOCT+

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Day to 14 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Presenting for an acute medical or surgical condition
Exclusion Criteria:
  • Presenting for scheduled consultation for a chronic disease (e.g. HIV, tuberculosis, non-communicable diseases, malnutrition)

  • Presenting for routine preventive care (e.g. growth monitoring, vitamin supplementation, deworming, vaccination)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Idiga Dispensary Idiga Mbeya Tanzania
2 Igoma Dispensary Igoma Mbeya Tanzania
3 Lwanjilo Dispensary Ilowelo Mbeya Tanzania
4 Inyala Health Center Inyala Mbeya Tanzania
5 Iwindi Dispensary Iwindi Mbeya Tanzania
6 Kimondo Dispensary Kimondo Mbeya Tanzania
7 Mbalizi Dispensary Mbalizi Mbeya Tanzania
8 Mjele Dispensary Mjele Mbeya Tanzania
9 Mshewe Dispensary Mjele Mbeya Tanzania
10 Mwabwowo Dispensary Mwabwowo Mbeya Tanzania
11 Santilya Health Center Santilya Mbeya Tanzania
12 Shuwa Dispensary Shuwa Mbeya Tanzania
13 Songwe viwandani Dispensary Songwe Mbeya Tanzania
14 Chikuti Dispensary Chikuti Morogoro Tanzania
15 Chirombora Dispensary Chirombora Morogoro Tanzania
16 Chita Rural Dispensary Chita Morogoro Tanzania
17 Idete Dispensary Idete Morogoro Tanzania
18 Idunda Dispensary Idunda Morogoro Tanzania
19 Kibaoni Health Center Ifakara Morogoro Tanzania
20 Michenga Dispensary Ifakara Morogoro Tanzania
21 Sagamaganga Dispensary Ifakara Morogoro Tanzania
22 Ketaketa Dispensary Ketaketa Morogoro Tanzania
23 Kichangani Dispensary Kichangani Morogoro Tanzania
24 Kisegese Dispensary Kisegese Morogoro Tanzania
25 Mbuga Dispensary Mbuga Morogoro Tanzania
26 Milola Dispensary Milola Morogoro Tanzania
27 Mngeta Health Center Mngeta Morogoro Tanzania
28 Sanje Dispensary Sanje Morogoro Tanzania
29 Sonjo Dispensary Sonjo Morogoro Tanzania
30 Udagaji Dispensary Udagaji Morogoro Tanzania
31 Utengule Dispensary Utengule Morogoro Tanzania
32 Isyesye Dispensary Mbeya Tanzania
33 Itagano Dispensary Mbeya Tanzania
34 Itensa Dispensary Mbeya Tanzania
35 Itezi Dispensary Mbeya Tanzania
36 Itijy Dispensary Mbeya Tanzania
37 Iyunga Health Center Mbeya Tanzania
38 Ndanyela Dispensary Mbeya Tanzania
39 Nzovwe Health Center Mbeya Tanzania
40 Tembela Dispensary Mbeya Tanzania

Sponsors and Collaborators

  • Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
  • Swiss Tropical & Public Health Institute
  • Ifakara Health Institute
  • Mbeya Medical Research Centre-National Institute for Medical Research

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
ClinicalTrials.gov Identifier:
NCT05901155
Other Study ID Numbers:
  • 2020-02800_substudymedalmentor
First Posted:
Jun 13, 2023
Last Update Posted:
Jun 13, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

Study Results

No Results Posted as of Jun 13, 2023